ONE LEVEL DEEPER
KHCThe Kraft Heinz Company
Consumer DefensivePackaged Foods
Analysis generated March 2026 · Data through Dec 2025

At 93rd percentile FCF yield with -8.32% growth implied, smart money accumulates while analysts capitulate.

Marks framework
Bullish

Revenue down -3.5% triggered -125.5% margins before recovering to 17.1% — a turnaround so volatile Lynch would look elsewhere.

Lynch framework
Leaning Bearish
1
THE BUSINESS MODEL

What does this company do and how does it make money?

Taste Elevation drives 45.2% of revenue at $11.3B, followed by Easy Ready Meals at 16.3% ($4.1B)
Geographic concentration: 67.3% from United States, 20.4% Rest of World, 7.2% Canada, 5.1% UK
TTM revenue declined -3.5% with negative net income of -$5.8B despite positive FCF of $3.7B
Nine product segments with Herfindahl index of 2558 indicating high concentration
Gross margins stable at 32.6% in Q4'25 vs 34.1% in Q4'24

Kraft Heinz operates a concentrated packaged foods portfolio where nearly half the revenue comes from one segment (Taste Elevation) and two-thirds from the US market. The company maintains stable gross margins around 33% but faces revenue headwinds, declining -3.5% annually while generating positive cash flow despite accounting losses.

Revenue by Segment
2
WHAT THE LEGENDS SEE

Five legendary investment frameworks analyzed this company.

Marks sees 93rd percentile cash yields while Lynch sees a turnaround without a catalyst — but nobody's asking why margins can swing 242 percentage points on a -3.5% revenue decline. Tap any framework below to explore their complete analysis and position on whether this extreme volatility creates opportunity or signals deeper problems.

Howard Marks framework
The Cycle Whisperer
Bullish
Michael Mauboussin framework
The Expectations Engineer
Bullish
Benjamin Graham framework
The Value Architect
Leaning Bullish
Warren Buffett framework
The Owner-Operator
Leaning Bullish
Peter Lynch framework
The Everyday Edge
Leaning Bearish
3
FOLLOW THE MONEY

How much cash does it generate and where does it go?

Q4'25 operating cash flow of $1.4B allocated 34.4% to dividends ($474M), 14.9% to capex ($205M)
TTM free cash flow of $3.7B despite negative net income of -$5.8B
FCF yield at 93rd percentile (4.09%) while stock trades at 16.5% of 52-week range
Minimal buybacks of $1M in Q4'25 vs consistent ~$475M quarterly dividends
SBC represents only 0.39% of Q4'25 revenue
Cash conversion cycle improved to 7.9 days in Q4'25

The company demonstrates remarkable cash generation with $3.7B in free cash flow despite reporting accounting losses, prioritizing dividends over buybacks. Management maintains disciplined capital allocation, paying consistent dividends even through operational volatility while keeping share-based compensation minimal.

Capital Allocation
4
CHECK THE TREND

Is the business getting stronger or weaker?

Operating margin collapsed to -125.5% in Q2'25 before recovering to 17.1% in Q4'25
Revenue declined -3.5% TTM with Q4'25 at $6.3B vs $6.4B in Q4'24
242.6 percentage point operating margin swing in just two quarters
Earnings quality shows deteriorating OCF vs net income divergence
Days inventory outstanding stable at 66.6 days in Q4'25

The business shows extreme operational volatility with margins swinging from deeply negative to positive in two quarters, while revenue continues declining. This massive margin recovery from -125.5% to 17.1% came entirely from cost cutting rather than revenue growth, raising questions about sustainability.

Operating Margin
5
KNOW THE RISKS

What could go wrong and has it survived trouble before?

Q2'25 operating loss of $7.97B with -125.5% margin shows extreme operational leverage
Taste Elevation segment concentration at 45.2% of revenue creates single-product risk
Net debt-to-EBITDA at 13.4x while debt-to-equity remains moderate at 0.51
Insiders shifted to net buying in Q1'26 with 827,631 shares after 13 quarters of selling
Manufactured beats in 29% of quarters indicates earnings management patterns

The company's extreme operational leverage means small revenue changes can trigger massive margin swings, as demonstrated by the Q2'25 collapse. High product concentration and elevated leverage ratios create vulnerability, though recent insider buying at $23 suggests management sees recovery ahead.

Insider Net Buying/Selling
INSTITUTIONAL FLOW
Marshall Wace, Llp added $832M
ACCUMULATING7/10 long-term · avg 32 qtrs
153new1,001existing1,154holders-13 net988staying166exited
Latest 13F filings · 2025-12-31 · 87.2% institutional ownership
INTERACTIVE
How would The Kraft Heinz Company's worst drawdowns feel?
INVESTED
$10,000
BOTTOM
$4,760
$5,240 lost. Recovery: Not recovered.

Operating margins swinging from -125.5% to +17.1% in two quarters reveals a business model built on volatility, not stability.

6
CHECK THE PRICE

Is the stock priced for perfection, fair value, or pessimism?

Trading at 11x earnings (28th percentile historically) with 2.27% earnings yield vs 4.33% treasury
Market implies -8.32% perpetual growth, well below any reasonable terminal rate
Stock at $22.79 trades 24.8% below DCF fair value of $30.29
Double beats generate only 1.41% gains while manufactured beats lose -1.63%
Analyst targets clustered at $24.38 with recent downgrades to Underweight

The market prices in permanent decline with an implied -8.32% growth rate, creating a significant gap between the 4.09% FCF yield and current valuation. Asymmetric earnings reactions show the market has lost faith in reported numbers, rewarding genuine beats minimally while punishing any earnings management.

Expectations Gap: DCF vs Market
DCF FAIR VALUE
$30
25% discount
MARKET PRICE
$23
Price implies -8.3% growth · Trailing: -3.5%
INTERACTIVE
Earnings Surprise Roulette
What type of surprise moves the stock most? Tap to find out.

Analysis applies published investment frameworks to publicly available financial data. Educational purposes only. Not financial advice.

Explore
Texas Instruments IncorporatedTXNArm Holdings plc American Depositary SharesARMBaker Hughes CompanyBKRFastenal CompanyFASTSeagate Technology Holdings plcSTXRegeneron Pharmaceuticals, Inc.REGN
EDUCATIONAL ONLY · NOT FINANCIAL ADVICEv2